✦ LIBER ✦

SY.2.3 UNDERSTANDING AND CIRCUMVENTING DAPTOMYCIN RESISTANCE IN TREATMENT OF STAPHYLOCOCCAL ENDOCARDITIS

✍ Scribed by Bayer, A.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SY.2.2 HIGH–DOSE DAPTOMYCIN IN THE THERA

✍ Rybak, M.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Long course of daptomycin in the treatme

✍ Matteo Bassetti; Małgorzata Mikulska; Eva Schenone; Laura Nicolini; Claudio Visc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 76 KB

SY.6.2 WHAT IS NEW IN THE PATHOGENESIS A

✍ Murray, B.E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

PIN26 A COST-EFFECTIVENESS ANALYSIS ON T

✍ F. García-Contreras; M. Martinez Revelles; B. Briones 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PIN3 Health Outcomes With Daptomycin (DA

✍ Forrest, G.; Larson, K.; Crompton, M.; Patel, H.; Boening, A.J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Effect of methotrexate treatment on expr

✍ Yoshihiko Shibayama; Kazami Ushinohama; Ryuji Ikeda; Yoshimi Yoshikawa; Toshiro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB